AMSTERDAM, Feb. 22, 2016 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will introduce a next-generation monitoring solution for at-risk patients in low acuity hospital settings, such as the general ward. As an industry-first, the new medical-grade biosensor enabled solution demonstrates Philips' continuing commitment to better addressing clinicians' and patients' needs through monitoring.
Unlike fitness trackers and consumer focused wearables, the new medical-grade, connected biosensor automatically and continuously measures clinically relevant vital signs including heart rate, respiratory rate, skin temperature and more. The biosensor then transmits the data it collects to a connected clinical decision support software application, where the software can be configured to promptly notify the appropriate caregiver or clinician when preset limits are exceeded.
"Driven by Philips' strong patient monitoring heritage, we are entering the emerging growth market of mobile health enabled solutions and services," said Carla Kriwet, CEO Patient Care and Monitoring Solutions at Philips. "We envision a future where patients enabled by connected health technologies will recover faster with fewer complications and greater peace of mind in the hospital and subsequently at home. We see the potential for connected sensing solutions and the value created by the rich and actionable data they generate to have a very positive impact on the chronically ill by helping to reduce associated costly adverse events, complications, unplanned transfers back to the ICU and longer lengths of hospitalization."
Philips' creation of this solution began from conversations with providers looking for rapid co-creation models to address specific issues, such as helping at-risk patients in low acuity hospital areas through recovery and transition to home care. Philips plans to introduce a portfolio of integrated solutions which will connect to analytics tools and dashboards with the goal to give clinicians actionable insights to help improve patient outcomes, reduce costs, and improve access to care.
Due to a growing aging population and a rising number of people with chronic diseases contributing to 86 percent of health care costs , healthcare stakeholders are seeking more cost-effective ways to monitor, diagnose and treat patients. While Philips' personal health programs will help consumers develop healthier habits for life and potentially prevent illness, Philips' connected health solutions for professional healthcare applications, including the wearable biosensor, are designed to help patients in low-acuity areas of the hospital transition home.
For more information on Philips' next-generation biosensor, visit booth #3416 at the 2016 Annual HIMSS Conference & Exhibition taking place Feb. 29 – March 4 at the Sands Expo in Las Vegas, NV. For updates on Philips' presence at HIMSS, follow @PhilipsLiveFrom and visit www.philips.com/himss.
For further information, please contact:
Steve Klink Philips Group Communications Tel.: +31 6 10888824 E-mail: email@example.com
Ingrid Mitchell Philips Patient Care and Monitoring Solutions Mobile: +1 617-599-6624 Email: firstname.lastname@example.org
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
SOURCE Royal Philips